Lessons learned from HPV vaccine delivery in low-resource settings and opportunities for HIV prevention, treatment, and care among adolescents

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue SUPPL. 2, 2014, Pages

  Tsu, Vivien D ^a   Cernuschi, Tania ^b   Lamontagne, D Scott ^a  

^a PATH   (United States)

^b GAVI Alliance Secretariat   (Switzerland)

Author keywords

adolescent health; HPV vaccine; low resource settings

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT DISEASE; ARTICLE; COMMUNITY; DEVELOPING COUNTRY; DRUG SAFETY; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFORMED CONSENT; INTEGRATION; LEISURE; MEDICAL DECISION MAKING; PATIENT CARE; PERU; PRIMARY SCHOOL; PRIORITY JOURNAL; SCHOOL; SOUTH AFRICA; STAFF TRAINING; SYSTEMATIC REVIEW; UGANDA; UTERINE CERVIX CANCER; VACCINATION; VIET NAM; VISUAL AID;

ADOLESCENT; AIDS VACCINES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS VACCINES; SOCIOECONOMIC FACTORS;

EID: 84902497650     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000175     Document Type: Article

References (53)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.
2. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.
3. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301-314.
4. World Health Organization. Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec. 2009;15:118-131.
5. Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 viruslike particle vaccine through 5 years of follow-up. Br J Cancer. 2006;95:1459-1466.
6. Roteli-Martins CM, Naud P, De Borba P, et al. Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up. Hum Vaccin Immunother. 2012;8:390-397.
7. Brotherton JM, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377:2085-2092.
8. Gertig DM, Brotherton JM, Budd AC, et al. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med. 2013;11:227.
9. Rana MM, Huhtala H, Apter D, et al. Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: cancer registry-based follow-up. Int J Cancer. 2013;132:2833-2838.
10. Kane MA, Sherris J, Coursaget P, et al. Chapter 15: HPV vaccine use in the developing world. Vaccine. 2006;24:S3/132-139.
11. Sherris J, Friedman A, Wittet S, et al. Chapter 25: education, training, and communication for HPV vaccines. Vaccine. 2006;24:S3/210-218.
12. World Health Organization and United Nations Population Fund. Preparing for the Introduction of HPV Vaccines: Policy and Program Guidance for Countries. Geneva, Switzerland: WHO; 2006.
13. Principi N, Esposito S. Adolescents and vaccines in the western world. Vaccine. 2013;31:5366-5374.
14. Global Education Digest 2012-Interactive Data Tool. UNESCO Institute for Statistics. Available at: http://www.uis.unesco.org/Education/Pages/ ged-2012-visualization.aspx. Accessed January 22, 2014.
15. Katahoire A, Jitta J, Kivumbi G, et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health. 2008; 12:159-172.
16. Jacob M, Mawar N, Menezes L, et al. Assessing the environment for introduction of human papillomavirus vaccine in India. The Open Vaccin J. 2010;3:96-107.
17. United Nations Population Fund (UNFPA). State of World Population 2013: Motherhood in Childhood, Facing the Challenge of Adolescent Pregnancy. New York, NY: UNFPA; 2013.
18. Bearinger LH, Sieving RE, Ferguson J, et al. Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet. 2007;369:1220-1231.
19. Tylee A, Haller D, Graham T, et al. Youth-friendly primary-care services: how are we doing and what more needs to be done? Lancet. 2007; 369:1565-1573.
20. LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middleincome countries. Bull World Health Organ. 2011;89:821-830B.
21. Penny M, Bartolini R. Evaluation of demonstration project 2010: health facility based immunization of 10 year old girls with HPV vaccine; part I: how does offering HPV vaccine in the health facility to 10 year old girls compare with a school based approach? Technical research report submitted to PATH; 2011.
22. Ladner J, Besson MH, Hampshire R, et al. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health. 2012;12:370.
23. Watson-Jones D, Baisley K, Ponsiano R, et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012;206:678-686.
24. Moodley I, Tathiah N, Mubaiwa V, et al. High uptake of Gardasil vaccine among 9-12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. S Afr Med J. 2013;103:313-317.
25. Singh Y, Shah A, Singh M, et al. Human papilloma virus vaccination in Nepal: an initial experience. Asian Pac J Cancer Prev. 2010;11:615-617.
26. Fregnani JH, Carvalho AL, Eluf-Neto J, et al. A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study. PLoS One. 2013;8:e62647.
27. Axios International. The Gardasil Access Program. Available at: http://www. gardasilaccessprogram.org/section/177. Accessed November 25, 2013.
28. PATH. Implementing HPV Vaccination Programs: Practical Experience From PATH. Seattle, WA: PATH; 2011. Cervical Cancer Prevention: Practical Experience Series.
29. Progress for children: A report card on adolescents. United Nations Children's Fund, Number 10, April 2012. Available at: http://www. unicef.org/media/files/PFC2012-A-report-card-on-adolescents.pdf. Accessed November 25, 2013.
30. Penny M, Bartolini R, Mosqueira NR, et al. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine. 2011;29:5022-5030.
31. Mugisha E, LaMontagne DS, Katahoire AR, et al. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda. Afr Health Sci. Provisional acceptance, August 26, 2013. In press.
32. LaMontagne DS, Nghi NQ, Nga LT, et al. Feasibility of HPV vaccination in Vietnam: evidence from a government-implemented demonstration program. BMC Public Health. 2013.
33. Bartolini RM, Winkler JL, Penny ME, et al. Parental acceptance of HPV vaccine in Peru: a decision framework. PLoS One. 2012;7:e48017.
34. Cover JK, Nghi NQ, LaMontagne DS, et al. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health. 2012;12:629.
35. Paul P, LaMontagne DS, Nga LT. Knowledge of cervical cancer and HPV vaccine post-vaccination among mothers and daughters in Vietnam. Asian Pac J Cancer Prev. 2012;13:2587-2592.
36. Galagan SR, Paul P, Menezes L, et al. Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine. 2013;31:3072-3078.
37. Katahoire A, Murokora D, Arube-Wani J, et al. Acceptability of HPV vaccine among young adolescent girls in Uganda: young people's perspectives count. Int J Child Adol Health. 2013;6:211-220.
38. Levin CE, Minh HV, Odaga J, et al. Incremental costs of strategies to deliver human papillomavirus vaccine to young adolescent girls in Peru, Uganda and Vietnam. Bull World Health Organ. 2013;91:585-592.
39. Binagwaho A, Wagner CM, Gatera M, et al. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90:623-628.
40. Quentin W, Terris-Prestholt F, Changalucha J, et al. Costs of delivering human papillomavirus vaccination to school girls in Mwanza region, Tanzania. BMC Med. 2012;10:137.
41. Watson-Jones D, Tomlin K, Remes P, et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One. 2012;7:e45231.
42. Wamai RG, Ayissi CA, Oduwo GO, et al. Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. J Community Health. 2012;37:917-926.
43. UNAIDS. Investing for Results. Results for People. A People-Centered Investment Tool Towards Ending AIDS. Geneva, Switzerland: UNAIDS; 2012. Available at: http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2012/JC2359-investing-for-results-en.pdf. Accessed November 25, 2013.
44. Plummer ML, Wight D, Wamoyi J, et al. Are schools a good setting for adolescent sexual health promotion in rural Africa? A qualitative assessment from Tanzania. Health Educ Res. 2007;22:483-499.
45. UNICEF. State of the World's Children. New York, NY: UNICEF; 2013. Available at: http://www.unicef.org/sowc2013/. Accessed November 15, 2013.
46. World Health Organization and UNICEF. Microplanning for Immunization Service Delivery Using the Reaching Every District (RED) Strategy. Geneva, Switzerland: World Health Organization; 2009. Available at: http://www.who.int/ immunization/sage/9-Final-RED-280909.pdf. Accessed November 17, 2013.
47. Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccines in low-resource settings. Arch Pediatr Adolesc Med. 2009;163:455-461.
48. Bartolini RM, Drake JK, Creed-Kanashiro HM, et al. Formative research to shape HPV vaccine introduction strategies in Peru (Investigación formativa para diseñar estrategias para la introducción de la vacuna contra el VPH en el Perú). Salud Pública de Méx. 2010;52:226-233.
49. Nghi NQ, LaMontagne DS, Bingham A, et al. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health. 2010;7:262-270.
50. WHO. Making Health Services Adolescent Friendly: Developing National Quality Standards for Adolescent Friendly Health Services. Geneva, Switzerland: WHO; 2012.
51. Kirby DB, Laris BA, Rolleri LA. Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world. Adolesc Health. 2007;40:206-217.
52. Napierala Mavedzenge SM, Doyle AM, Ross DA. HIV prevention in young people in sub-Saharan Africa: a systematic review. J Adolesc Health. 2011;49:568-586.
53. WHO. Review of the Social Determinants and the Health Divide in the WHO European Region: Final Report. Copenhagen, Denmark: WHO; 2013. Available at: http://www.euro.who.int/data/assets/pdf-file/0006/ 215196/Review-of-social- determinants-and-the-health-divide-in-the-WHOEuropean-Region-final-report-Eng. pdf. Accessed January 21, 2014.